- Filed
- Apr 30, 2025 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · Apr 25, 2025 | 22.47M sh |
| Long Term Debt | Q1 2025 · Mar 31, 2025 | $1.35M |
| Long Term Debt | Q1 2025 · Dec 31, 2024 | $1.78M |
| Short Term Debt | Q1 2025 · Mar 31, 2025 | $1.77M |
| Short Term Debt | Q1 2025 · Dec 31, 2024 | $1.77M |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $42.16M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $42.1M |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $12.57M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $9.91M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $17.2M |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $15.2M |
| Current Assets | Q1 2025 · Mar 31, 2025 | $66.75M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $64.2M |
| Total Assets | Q1 2025 · Mar 31, 2025 | $80.23M |
| Total Assets | Q1 2025 · Dec 31, 2024 | $77.79M |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 21.25M sh |
| Capex | Q1 2025 · Mar 31, 2024 | $1.21M |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | −$1.29M |
| Stockholders Equity | Q1 2025 · Mar 31, 2024 | $55.79M |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | $53.92M |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | −$0.01 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | −$0.01 |
| Sga Expense | Q1 2025 · Mar 31, 2024 | $4.04M |
| Rd Expense | Q1 2025 · Mar 31, 2024 | $3.42M |
| Net Income | Q1 2025 · Mar 31, 2024 | −$202K |
| Operating Income | Q1 2025 · Mar 31, 2024 | −$600K |
| Gross Profit | Q1 2025 · Mar 31, 2024 | $8.16M |
| Cost Of Revenue | Q1 2025 · Mar 31, 2024 | $6.27M |
| Revenue | Q1 2025 · Mar 31, 2024 | $14.43M |